TradingView
TopgOptions
Dec 15, 2021 2:03 PM

OCGN COVAXIN Robust Immune Memory to COVID-19 and Variants Long

NASDAQ:OCGN1D
Ocugen, Inc.NASDAQ

Description

⋅
New Data suggest COVAXIN (BBV152) may provide protection against current and future variants!

data from a Phase 3 trial that included nearly 25,800 participants: 77.8% overall efficacy, 93.4% efficacy against severe illness and 65.2% efficacy against the Delta variant.

52 Week Range 0.28 - 18.77

My price target is the 10.30usd resistance.
Trend AnalysisTechnical IndicatorsFundamental AnalysisOCGNogcnstockocugenvaccinecovidvaccineCoronavirus (COVID-19)coronavirusstocksvaccinestocksbuy
Comments
LeonSprey12
⋅
Great news for us.! Been holding Ocugen since $0.3 got it on 1:100 leverage. Retirement is looking good
TopgOptions
⋅
@LeonSprey12, wow, congrats!
GratefulGains
⋅
I like when you post on stock I hold cause I know something is going to happen
TopgOptions
⋅
@GratefulGains, :))
Mrprinter
⋅
the way this keeps dipping is bad do you guys really think this is possible i mean by last year i would think it looks due for another spike but just keeps goig down even with good news
TopgOptions
⋅
@Mrprinter, it will go up on Monday.
StarWeek143
⋅
@CryptoFundManager @CryptoFundManager what will be your PT please would you share?
TopgOptions
⋅
@StarWeek143, 10.3 is the first price target.
StarWeek143
⋅
@CryptoFundManager ThankYou will keep eye tomorrow.
StarWeek143
⋅
@CryptoFundManager it have to break 6.80 to reach 9 is that not right? m still learning charts so not that expert like you. But will surely hope and wish it reach 10
More